Enocitabine Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Enocitabine (NSC-239336, BHAC) is an antileukemic agent closely related to cytarabine. It appears more resistant to deamination than cytarabine, thus allowing greater in vivo phosphorylation into an active cytotoxic metabolite. Enocitabine is lipophilic, but the drug does not enter the cerebrospinal fluid and is concentrated in the bone marrow and red blood cells. It can be administered orally and appears to be more effective than the parent compound in preclinical models.

Chemische Eigenschaften

Crystalline Solid

Enocitabine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Enocitabine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Beijing Yibai Biotechnology Co., Ltd	0086-182-6772-3597	sales04@yibaibiotech.com	CHINA	419	58
CONIER CHEM AND PHARMA LIMITED	+8618523575427	sales@conier.com	China	49979	58
career henan chemical co	+86-0371-86658258 +8613203830695	factory@coreychem.com	China	29792	58
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32466	58
Dayang Chem (Hangzhou) Co.,Ltd.	+86-0571-88938639 +8617705817739	info@dycnchem.com	China	52704	58
NewCan Biotech Limited	+86-571-86912261 19975279805	sales@newcanbio.com	China	9985	58
InvivoChem	+1-708-310-1919 +1-13798911105	sales@invivochem.cn	United States	6391	58
GIHI CHEMICALS CO.,LIMITED	+86-571-86217390; +8618058761490	info@gihichemicals.com	China	49954	58
Zibo Hangyu Biotechnology Development Co., Ltd	+86-0533-2185556 +8615965530500	nickzhang@hangyubiotech.com	China	9947	58
Henan Fengda Chemical Co., Ltd	+86-371-86557731 +86-13613820652	info@fdachem.com	China	20122	58

55726-47-1()Verwandte Suche:

---

• N-(1-BETA-D-ARABINOFURANOSYL-1,2-DIHYDRO-2-OXO-4-PYRIMIDINYL)DOCOSANAMIDE
• NSC-239336
• SUNRABIN
• BEHENOYLCYTOSINE ARABINOSIDE
• BH-AC
• ENOCITABINE
• n-(1-beta-d-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-docosanamid
• n(sup4)-behenoyl-1-beta-d-arabinofuranosylcytosine
• n(sup4)-behenoylcytosinearabinoside
• N-[1-[(2R,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-pyrimidin-4-yl]docosanamide
• 1-β-D-Arabinofuranosyl-4-(1-oxodocosyl)amino-1,2-dihydropyrimidin-2-one
• Enocitabine API
• N-(1-B-D-Arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)docosanamide, Behenoylcytosine Arabinoside, BH-AC, NSC-239336, Sunrabin
• Docosanamide, N-(1-β-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-
• N4-Behenoyl-1-β-D-arabinofuranosylcytosine
• N4-Behenoylcytosine arabinoside
• N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide
• ENOCITABINE 98.5+% ANTINEOPLASTIC DRUGS
• N-[1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide Enocitabine
• CS-1807
• 1-benzimidazolyl-(5-bromo-2-furanyl)methanone
• N(4)-behenoyl-1-beta-arabinofuranosylcytosine
• N-(1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)docosanamide
• Inhibitor,CMV,Enocitabine,inhibit,DNA/RNA Synthesis,Sunrabin,Cytomegalovirus,AML,acute myelogenous leukaemia,Nucleoside Antimetabolite/Analog
• N-{1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxo-1,2-dihydropyrimidin-4-yl}docosanamide
• Docosanamide,N-(1-b-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-
• 55726-47-1
• C31H55N3O6
• Intermediates & Fine Chemicals
• Pharmaceuticals